Related Experiment Videos

Minor and major patients--what can be done?

Garry Swann¹, Mark Roberts, Elaine Whotton

¹Derbyshire Royal Infirmary, Southern Derbyshire Acute Hospitals NHS Trust.

Emergency Nurse : the Journal of the RCN Accident and Emergency Nursing Association

|May 8, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A 5' UTR CCG expansion in TBC1D7 causes oculopharyngodistal myopathy.

medRxiv : the preprint server for health sciences·2026

Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.

Therapeutic advances in rare disease·2026

Correction: Cross-sectional validation of the PROMIS-Preference scoring system.

PloS one·2025

Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial.

Journal of neurology·2025

Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL.

Muscle & nerve·2025

Real-Time Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control: Clinical and Economic Impact.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

See all related articles